Digestive Diseases and Sciences

, Volume 59, Issue 7, pp 1392–1397

Irritable Bowel Syndrome May Be Associated with Maternal Inheritance and Mitochondrial DNA Control Region Sequence Variants

  • Miranda A. L. van Tilburg
  • Essam A. Zaki
  • Thangam Venkatesan
  • Richard G. Boles
Original Article

Abstract

Background and Aim

Mitochondrial dysfunction has been implicated in various functional disorders that are co-morbid to irritable bowel syndrome (IBS) such as migraine, depression and chronic fatigue syndrome. The aim of the current case–control pilot study was to determine if functional symptoms in IBS show a maternal inheritance bias, and if the degree of this maternal inheritance is related to mitochondrial DNA (mtDNA) polymorphisms.

Methods

Pedigrees were obtained from 308 adult IBS patients, 102 healthy controls, and 36 controls with inflammatory bowel disease (IBD), all from Caucasian heritage, to determine probable maternal inheritance. Two mtDNA polymorphisms (16519T and 3010A), which have previously been implicated in other functional disorders, were assayed in mtDNA haplogroup H IBS subjects and compared to genetic data from 344 published haplogroup H controls.

Results

Probable maternal inheritance was found in 17.5 % IBS, 2 % healthy controls and 0 % IBD controls (p < .0001). No difference was found between IBS and control for 3010A, and a trend was found for 16519T (p = 0.05). IBS with maternal inheritance were significantly more likely to have the 16519T than controls (OR 5.8; 95 % CI 1.5–23.1) or IBS without maternal inheritance (OR 5.2; 95 % CI 1.2–22.6).

Conclusions

This small pilot study shows that a significant minority (1/6) of IBS patients have pedigrees suggestive of maternal inheritance. The mtDNA polymorphism 16519T, which has been previously implicated in other functional disorders, is also associated with IBS patients who display maternal inheritance. These findings suggest that mtDNA-related mitochondrial dysfunction may constitute a sub-group within IBS. Future replication studies in larger samples are needed.

Keywords

Functional gastrointestinal disorders Genetics Cellular energy metabolism Co-morbidity 

Abbreviations

IBD

Inflammatory bowel disease

IBS

Irritable bowel syndrome

mtDNA

Mitochondrial DNA

Supplementary material

10620_2014_3045_MOESM1_ESM.pptx (55 kb)
Figure a: Example of a pedigree with maternal inheritance pattern (PPTX 54 kb)
10620_2014_3045_MOESM2_ESM.pptx (73 kb)
Figure b: Graph of maternal symptoms per relative by maternal inheritance ratios for irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and healthy controls (PPTX 73 kb)

References

  1. 1.
    Choung RS, Locke GR III. Epidemiology of IBS. Gastroenterol Clin N Am. 2011;40:1–10.CrossRefGoogle Scholar
  2. 2.
    Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–1156.PubMedCrossRefGoogle Scholar
  3. 3.
    Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008;20:790–797.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–1562.PubMedCrossRefGoogle Scholar
  5. 5.
    Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia. 1996;16:305–309.PubMedCrossRefGoogle Scholar
  6. 6.
    Gardner A, Boles RG. Mitochondrial energy depletion in depression with somatization. Psychother Psychosom. 2008;77:127–129.PubMedCrossRefGoogle Scholar
  7. 7.
    Gardner A, Johansson A, Wibom R, et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 2003;76:55–68.PubMedCrossRefGoogle Scholar
  8. 8.
    Buchsbaum MS, Wu J, DeLisi LE, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord. 1986;10:137–152.PubMedCrossRefGoogle Scholar
  9. 9.
    Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia. 1995;15:323–327.PubMedCrossRefGoogle Scholar
  10. 10.
    Ruiz-Pesini E, Lott MT, Procaccio V, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007;35:D823–D828.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Smeitink JA. Mitochondrial disorders: clinical presentation and diagnostic dilemmas. J Inherit Metab Dis. 2003;26:199–207.PubMedCrossRefGoogle Scholar
  12. 12.
    Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29:719–728.PubMedCrossRefGoogle Scholar
  13. 13.
    Boles RG, Adams K, Li BU. Maternal inheritance in cyclic vomiting syndrome. Am J Med Genet A. 2005;133A:71–77.PubMedCrossRefGoogle Scholar
  14. 14.
    Burnett BB, Gardner A, Boles RG. Mitochondrial inheritance in depression, dysmotility and migraine? J Affect Disord. 2005;88:109–116.PubMedCrossRefGoogle Scholar
  15. 15.
    Bergemann ER, Boles RG. Maternal inheritance in recurrent early-onset depression. Psychiatr Genet. 2010;20:31–34.PubMedCrossRefGoogle Scholar
  16. 16.
    Higashimoto T, Baldwin EE, Gold JI, et al. Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance. Arch Dis Child. 2008;93:390–397.PubMedCrossRefGoogle Scholar
  17. 17.
    Camilleri M, Carlson P, Zinsmeister AR, et al. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol. 2009;296:G510–G516.PubMedCrossRefGoogle Scholar
  18. 18.
    Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene. 1999;238:211–230.PubMedCrossRefGoogle Scholar
  19. 19.
    van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30:E386–E394.PubMedCrossRefGoogle Scholar
  20. 20.
    Cheng S, Fockler C, Barnes WM, et al. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA. 1994;91:5695–5699.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Wang WF, Li X, Guo MZ, et al. Mitochondrial ATP 6 and 8 polymorphisms in irritable bowel syndrome with diarrhea. World J Gastroenterol. 2013;19:3847–3853.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Whitehead WE, Palsson OS, Levy RR, et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol. 2007;102:2767–2776.PubMedCrossRefGoogle Scholar
  23. 23.
    Fattal O, Link J, Quinn K, et al. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007;12:429–438.PubMedGoogle Scholar
  24. 24.
    Slater SK, Nelson TD, Kabbouche MA, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31:897–905.PubMedCrossRefGoogle Scholar
  25. 25.
    Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64:713–715.PubMedCrossRefGoogle Scholar
  26. 26.
    Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007;47:73–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22:137–141.PubMedCrossRefGoogle Scholar
  28. 28.
    Cordero MD, Cano-Garcia FJ, Alcocer-Gomez E, et al. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q(1)(0) effect on clinical improvement. PLoS One. 2012;7:e35677.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Cordero MD, Alcocer-Gomez E, de Miguel M, et al. Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? Case series with 5 patients. Mitochondrion. 2011;11:623–625.PubMedCrossRefGoogle Scholar
  30. 30.
    Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, l-carnitine and amitriptyline, a case series. BMC Neurol. 2011;11:102.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Boles RG, Lovett-Barr MR, Preston A, et al. Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol. 2010;10:10.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Miranda A. L. van Tilburg
    • 1
  • Essam A. Zaki
    • 2
    • 3
  • Thangam Venkatesan
    • 4
  • Richard G. Boles
    • 2
    • 3
  1. 1.Center for Functional GI and Motility DisordersUniversity of North CarolinaChapel HillUSA
  2. 2.Division of Medical GeneticsChildren’s Hospital Los AngelesLos AngelesUSA
  3. 3.Department of Pediatrics, Keck School of MedicineUSCLos AngelesUSA
  4. 4.Department of Gastroenterology and HepatologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations